Lupin Bepogra Tablet contains Bepotastine 10mg, a selective histamine H1 receptor antagonist used primarily for the treatment of allergic conditions. Bepotastine exhibits potent antihistaminic activity by competitively inhibiting the binding of histamine to H1 receptors, thereby alleviating symptoms associated with allergic rhinitis, urticaria, and other hypersensitivity reactions. Its rapid onset of action and minimal sedative effects make it suitable for patients requiring effective symptom control without significant central nervous system depression. The tablet formulation ensures convenient oral administration with good bioavailability. Lupin Bepogra is indicated for the relief of nasal congestion, sneezing, itching, rhinorrhea, and ocular symptoms such as itching and redness related to allergic conjunctivitis. It is generally well tolerated, with adverse effects being mild and infrequent, including headache, dry mouth, and gastrointestinal discomfort. Caution is advised in patients with known hypersensitivity to Bepotastine or any tablet excipients. Dose adjustment may be necessary in hepatic or renal impairment. Lupin Bepogra should be used under medical supervision, particularly in pregnant or lactating women, and in combination with other central nervous system depressants. This medication offers an effective and safe option for managing allergic symptoms, improving patient quality of life.